Parion Sciences Receives NIH Biodefense Grant To Study Novel Methods For Mitigating Radiation-Induced Lung Injury

Parion Sciences, Inc., a privately-held, development-stage pharmaceutical company dedicated to treating diseases resulting from the failure of the body’s mucosal defenses, today announced that the National Institutes of Health (NIH) have awarded the company a biodefense grant in excess of $850,000.

More: continued here

Filed under: Radiology on December 19th, 2008